Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

Contact Us

Search

Inherited retinal diseases

Cell_Gene_Therapy

Cell and Gene Therapy Today—January 22, 2026

This week’s updates highlight significant advancements in gene and cell…

EURETINA 2025 Preview: Key Retinal Disease Highlights to Watch

EURETINA 2025 at a glance Looking ahead to EURETINA 2025, LucidQuest outlines…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Immunology Today—February 4, 2026
Women’s Health Video Recap—February 4, 2026
Neuroscience Video Recap—February 4, 2026
Neuroscience Today—February 4, 2026
Lucid Diligence Brief: ZipBio licenses its AI-designed GA AAV program to MeiraGTx

Tags

advanced therapies Antengene bioinformatics blood test cancer Cardiovascular market trends Central nervous system diseases Chronic disease management Chugai ckd CONMED corporate venture capital drug pricing drug supply chain Elranatamab ESMO 2021 gene editing gene therapy approval Glaucoma Harbour BioMed Health systems innovation hematology Hormone therapy development Human Metapneumovirus investment Mass General Brigham MindRank nanotechnology NFTs in healthcare non-dilutive funding non viral vectors oncology trials organizations OpenAI OX40 pathway PD-1 combinations pharma Pimicotinib Pulmonary disease treatments remote patient monitoring scientific computing Sema4 Tahoe Therapeutics tissue engineering Tvardi Therapeutics unconventional trial designs

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Immunology Today—February 4, 2026
Women’s Health Video Recap—February 4, 2026
Neuroscience Video Recap—February 4, 2026
Neuroscience Today—February 4, 2026
Lucid Diligence Brief: ZipBio licenses its AI-designed GA AAV program to MeiraGTx

TAGS

advanced therapies Antengene bioinformatics blood test cancer Cardiovascular market trends Central nervous system diseases Chronic disease management Chugai ckd CONMED corporate venture capital drug pricing drug supply chain Elranatamab ESMO 2021 gene editing gene therapy approval Glaucoma Harbour BioMed Health systems innovation hematology Hormone therapy development Human Metapneumovirus investment Mass General Brigham MindRank nanotechnology NFTs in healthcare non-dilutive funding non viral vectors oncology trials organizations OpenAI OX40 pathway PD-1 combinations pharma Pimicotinib Pulmonary disease treatments remote patient monitoring scientific computing Sema4 Tahoe Therapeutics tissue engineering Tvardi Therapeutics unconventional trial designs

Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy